Genpact Limited (NYSE:G) SVP Heather White Sells 15,513 Shares of Stock

Genpact Limited (NYSE:G) SVP Heather White sold 15,513 shares of the stock in a transaction dated Tuesday, January 12th. The stock was sold at an average price of $41.14, for a total transaction of $638,204.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Genpact stock opened at $40.88 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.64 and a current ratio of 1.64. Genpact Limited has a 52-week low of $19.41 and a 52-week high of $45.20. The firm has a 50 day moving average price of $41.25 and a two-hundred day moving average price of $39.52. The firm has a market cap of $7.74 billion, a price-to-earnings ratio of 25.39, a PEG ratio of 2.36 and a beta of 1.32.

Genpact (NYSE:G) last released its quarterly earnings results on Monday, November 2nd. The business services provider reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.07. The firm had revenue of $935.50 million during the quarter, compared to analyst estimates of $903.78 million. Genpact had a net margin of 8.53% and a return on equity of 21.81%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.56 EPS. As a group, equities research analysts predict that Genpact Limited will post 1.8 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 23rd. Stockholders of record on Wednesday, December 9th were given a dividend of $0.0975 per share. This is an increase from Genpact’s previous quarterly dividend of $0.10. The ex-dividend date of this dividend was Tuesday, December 8th. This represents a $0.39 annualized dividend and a dividend yield of 0.95%. Genpact’s dividend payout ratio (DPR) is 25.00%.

Several hedge funds have recently made changes to their positions in G. Huntington National Bank grew its position in Genpact by 42.5% in the 4th quarter. Huntington National Bank now owns 1,486 shares of the business services provider’s stock valued at $61,000 after purchasing an additional 443 shares during the period. Cerebellum GP LLC acquired a new stake in Genpact in the 3rd quarter valued at $59,000. Advisors Asset Management Inc. grew its position in Genpact by 163.6% in the 3rd quarter. Advisors Asset Management Inc. now owns 1,732 shares of the business services provider’s stock valued at $67,000 after purchasing an additional 1,075 shares during the period. World Asset Management Inc acquired a new stake in Genpact in the 3rd quarter valued at $203,000. Finally, PNC Financial Services Group Inc. grew its position in Genpact by 39.1% in the 2nd quarter. PNC Financial Services Group Inc. now owns 5,631 shares of the business services provider’s stock valued at $205,000 after purchasing an additional 1,584 shares during the period. 81.99% of the stock is owned by institutional investors.

A number of brokerages recently issued reports on G. BMO Capital Markets dropped their price objective on shares of Genpact from $48.00 to $42.00 and set a “market perform” rating for the company in a report on Tuesday, November 3rd. Needham & Company LLC dropped their price objective on shares of Genpact from $48.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday, November 3rd. Finally, BidaskClub lowered shares of Genpact from a “hold” rating to a “sell” rating in a report on Wednesday, December 30th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $43.89.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.

Read More: Fundamental Analysis